Daniel Pearson

Daniel Pearson has a long and varied career in the field of research and development. Daniel began their career in 1985 as a Section Research Chemist at DuPont, where they were responsible for preparing novel chelators for technetium-99m to support an imaging program for the diagnosis of cancer. Daniel also developed a novel method to scavenge protecting groups in Fmoc-based solid-phase peptide synthesis using trialkylsilanes. In 1989, they moved to Immunetech Pharmaceuticals as a Senior Scientist, where they synthesized novel RGD mimetics for binding to GP\uf0614\uf0621 and GP\uf0615\uf0621 integrins, as well as developed a parallel solid-phase synthesis program for the production of diketopiperazines. In 1990, they became a Group Leader at Corvas International, supervising a group of six chemists involved in the production of aldehyde and ketoamide antithrombotic agents (thrombin and Xa inhibitors) using novel solid-phase synthesis techniques. In 1994, they moved to Diatide as an Associate Director of Chemistry, where they supervised 4 chemists and developed an effective research program. In 2001, they became Director of Chemistry at EPIX Medical, supervising 7 Ph.D. scientists in the development of novel magnetic resonance imaging contrast agents. In 2002, they moved to Clark & Elbing LLP as a Technology Specialist, where they were responsible for patent prosecution in the fields of pharmaceuticals, biochemistry, and cell biology. In 2005, they became a Patent Agent at Vertex Pharmaceuticals, where they were responsible for the preparation and prosecution of patents related to the treatment of cancer, infectious disease, inflammatory disease, and autoimmune disease. From 2013 to 2019, they worked as a Consultant for Trek Therapeutics, Woodland Pharmaceuticals, and Sefacor Inc. In 2019, they became an Intellectual Property Manager at Enko. Daniel has also been self-employed as a Freelance Technical Writer since 1996, where their ability to clarify scientific findings in writing was of prime importance.

Daniel Pearson completed post-doctoral study in Organic Chemistry at Columbia University from 1983 to 1985. Prior to that, they earned a Doctor of Philosophy (PhD) in Chemistry from Brandeis University from 1978 to 1983.